Introduction
============

There have been significant achievements in the development of multifunctional nanoparticles, which have stimulated various biomedical research areas, including molecular imaging, cancer therapy, and drug delivery [@B1]-[@B5]. In particular, photoactive nanoparticles have been widely used as diagnostic and therapeutic agents with laser irradiation [@B6], [@B7]. When photoactive nanoparticles are irradiated with nanosecond pulsed laser light, they heat up and generate acoustic waves that can be used for photoacoustic (PA) imaging. PA imaging is regarded as an emerging non-invasive imaging technique that provides high ultrasonic resolution and strong, optically sensitive images in deep tissues because of a laser-induced PA effect [@B8]-[@B10]. Because of its hybrid properties, the PA imaging technique provides *in vivo*deep tissue high-resolution anatomical, functional, and molecular images [@B11]-[@B19]. In another study, continuous-wave laser irradiation of a photo-activated nanoparticle-injected region was used to generate a temperature increase in a selected area; this technique was used as photothermal therapy (PTT) for tumor ablation. PTT has received attention because it facilitates selective tumor ablation and minimizes damage to normal tissues [@B20]-[@B23]. Therefore, it could be advantageous to combine contrast agent-based PA imaging and PTT within a single probe for use in disease diagnosis and therapy.

Among the various types of nanoparticles, metallic nanoparticles, such as gold-based nanostructures [@B2], [@B24]-[@B29], carbon-based nanoparticles [@B25], [@B30], [@B31], and organic nanoparticles [@B32]-[@B36], have been reported as multifunctional nanoparticles for PA imaging and PTT because of their strong photo-absorbing abilities. Unfortunately, even for the metallic nanoparticles that have shown excellent performance, their photostability, biocompatibility, and biodegradability remain critical issues for true clinical translation. For example, long-term laser irradiation of gold nanoparticles can cause morphological changes and will generally cause changes in the optical properties of the nanoparticles and reduce absorbance [@B37], [@B38]. Additionally, gold nanoshells coated with polyethylene glycol 5000 have been shown to be difficult to excrete from the body [@B39], and the use of surfactants during gold nanorod synthesis has been shown to cause toxicity [@B40], [@B41]. Thus, alternative agents with strong absorbance must maintain the optical stability and biodegradability of the nanoparticles.

Carbon nanoparticles are regarded as being relatively more stable and biocompatible than are the nanostructures described above [@B42], [@B43]. Carbon nanodots (CNDs) are promising carbon-based imaging probes that have attracted much attention because of their properties, including excellent biocompatibility, water solubility, and photostability [@B44]-[@B51]. Recently, several studies have successfully demonstrated the feasibility of using CNDs as imaging probes [@B52]-[@B57], but the main challenge for practical applications is to guarantee biodegradability. Furthermore, the fundamental mechanism of how CNDs interact with low-energy photons should be studied to improve their optical properties related to image resolution and contrast.

In this study, we synthesized biocompatible, near-infrared (NIR)-absorbing N-doped CNDs (N-CNDs) for PA imaging and PTT by carbonizing organic acids with a controllable nitrogen source. The synthesized N-CNDs showed excellent photostability and strong optical absorbance in the NIR region, where tissue and hemoglobin show small optical absorption. Thus, the PA signals from N-CNDs were high enough to detect inside living animals, and minimally invasive PTT using N-CNDs was possible. We performed time-resolved PA imaging of sentinel lymph nodes (SLNs) and assessed renal clearance after hypodermic injection to investigate the biodegradability and potential application of N-CNDs as a PA imaging contrast agent. Degradation and cytotoxic tests were also performed to further verify the biodegradability of N-CNDs. Finally, we treated the liver cancer tumor on the mouse skin using photothermal ablation with N-CNDs injected near the tumor region.

2. Materials and Methods {#Section2}
========================

2.1 Synthesis of N-CNDs {#Section2.1}
-----------------------

An aqueous solution of citric acid was prepared by dissolving citric acid (1 g) in water (1 mL). The aqueous solution of citric acid was transferred into a round-bottom flask containing oleylamine (1 mL) and octadecene (9 mL). To the mixture under vigorous stirring, 0, 1, 3, 5, 7, 10, 12, and 14 M (conc.) solutions of nitric acid (1 mL) were added for synthesizing N0-, N1-, N3-, N5-, N7-, N10-, N12-, and N14-CNDs, respectively. The mixture was then heated for 3 h at 250°C. The resulting solution (5 mL) was mixed with methanol (40 mL) and then separated by centrifugation at 3,000 rpm for 15 min, which was repeated three times. After drying in a vacuum oven overnight, the resulting viscous liquid (50 mg) was re-dispersed in toluene (5 mL), and to this solution, ethanolamine (15 mL) was added. The mixture was then heated at 100°C under vigorous stirring until solid remained. The resulting solid was dissolved in water (10 mL) and then dialyzed against water three times (24 h for each time) using Spectra/Por Biotech Cellulose Ester dialysis tubes (100-500 Da). The water was removed from the resulting solution by freeze-drying. The resulting solid (N-CNDs) was stored in a freezer for further use.

2.2 PA imaging system {#Section2.2}
---------------------

All *in vitro*, *in vivo,* and *ex vivo*PA experiments were conducted using an acoustic-resolution reflection-mode PA imaging system (Figure [S1](#SM1){ref-type="supplementary-material"}). A Q-switched Nd:YAG laser (SLII-10; Continuum) at 532-nm optical wavelength was used for pumping a tunable OPO laser (Surelite OPOPLUS; Continuum), which provided a 5-ns pulse duration over the wavelength tuning range of 680 to 2500 nm at a 10-Hz repetition rate. To avoid PA signal generation from the surface, the irradiated laser beam had a donut-shaped pattern achieved by passing through a conical lens and an optical condenser. The pulsed laser energy was \~5 mJ/cm^2^, which is much less than the American National Standards Institute standard limit (\~20 mJ/cm^2^). A wavelength of 680 nm was used for *in vivo*PA imaging. A spherically focused ultrasonic transducer with a 5-MHz center frequency (V308; Olympus NDT) was applied for detecting the generated PA signals. A pulser/receiver (5072PR, Olympus NDT) and a digital oscilloscope (MSO 5204; Tektronix) were used for amplifying the PA signal and recoding, respectively. Two linear scanners were used to perform raster scanning to obtain volumetric PA imaging. To improve the acoustic coupling efficiency, a homemade water tank and ultrasound gel were used. The animals were then placed on a sample stage for SLN and bladder imaging. The 5-MHz ultrasonic transducer induced axial and lateral resolutions of 145 and 950 μm, respectively. It takes approximately 30 mins to acquire one three-dimensional PA image.

2.3 In vitro/in vivo/ex vivo PA imaging setup {#Section2.3}
---------------------------------------------

To measure the *in vitro* PA sensitivity and spectrum of N-CNDs, eight silicon tubes were prepared with a N0-, N1-, N3-, N5-, N7-, N10-, N12-, and N14-CNDs at the same concentration (20 mg/mL) by tuning the laser wavelength from 680 to 950 nm. Moreover, to compare the PA amplitude of N-CNDs with those of conventional materials at the same optical density of 0.6 mm^-1^, we measured the PA signal amplitudes of three silicon tubes containing gold nanorod (GNR), methylene blue (MB), and N-CNDs under 680-nm pulsed laser excitation. Furthermore, to investigate the stability of the PA response, GNR, MB, and N-CNDs (20 mg/mL) were also compared by monitoring the PA amplitudes during 1,100 pulsed laser shots of 15 mJ/cm^2^.

We satisfied the guidelines of the university on the care and utilization of laboratory animals in all animal experiments. For *in vivo* and *ex vivo* SLN PA imaging, female Sprague-Dawley rats (weight: \~250 g) were fully anesthetized by using a vaporized-isoflurane system. After removing the hair of the left-side axillae, the rat was placed on the sample stage. The left-side axillae vasculature networks and lymphatic system of the rats before and after hypodermic injection of N-CNDs (0.1 mL, 20 mg/mL) (n = 3) were photoacoustically visualized. After completing *in vivo* PA imaging, we performed validation by performing *ex vivo* PA imaging of extracted lymph nodes. For *in vivo* whole-body PA imaging, female Balb/c nu/nu mice (Weight: \~20 g) were prepared under full anesthetization. After obtaining control whole-body PA images of the abdomen side with an invisible bladder, the N-CNDs (0.1 mL, 20 mg/mL) (n = 3) were subcutaneously delivered into the left leg. Then, we photoacoustically monitored the visualization of the bladder over 280 min.

2.4 PTT materials {#Section2.4}
-----------------

Dulbecco\'s modified Eagle\'s medium (DMEM), fetal bovine serum (FBS), antibiotics, and phosphate-buffered solution (PBS) were purchased from Invitrogen (Carlsbad, CA). 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) was supplied from Sigma-Aldrich (St. Louis, MO). Calcein-AM and propidium iodide (PI) were obtained from AnaSpec (Fremont, CA). The 8-chamber glass slides with polystyrene vessels were purchased from BD Falcon (Franklin Lakes, NJ).

2.5 Photothermal performance of N-CNDs {#Section2.5}
--------------------------------------

N-CNDs were dissolved in PBS at different concentrations (0 mg/mL to 20 mg/mL). Each N-CNDs solution (1 mL) was introduced in a quartz cuvette and irradiated with 808-nm laser light at a power density of 2 W/cm^2^ for 10 min. To observe the photothermal characteristics of N-CNDs, a thermocouple probe was inserted into the cuvette to contact the N-CNDs solution, and the temperature was recorded every 30 s. PBS was used as a negative control.

2.6 Confocal microscopy for cellular uptake {#Section2.6}
-------------------------------------------

Normal mouse liver hepatocyte cells (FL83B) and human liver cancer cells (HepG2) were cultured in high-glucose DMEM supplemented with 10 vol% of FBS at 37°C in an incubator. The cells were seeded in the 8-chamber confocal slide at a density of 4 × 10^4^ cells/well and incubated for a day. Then, N-CNDs solutions (10 mg/mL) in 200 μL of DMEM were added to the wells. The cellular uptake of N-CNDs was assessed by confocal microscopy. The emission light of N-CNDs was spectrally resolved into four channels. We observed strong blue, green, and yellow fluorescence from N-CNDs-labeled cells depending on the excitation wavelength, and less fluorescence was observed from the control group.

2.7 Cytotoxic test {#Section2.7}
------------------

FL83B cells and HepG2 cells were seeded in a 96-well plate at 1 × 10^4^ cells/well and cultured in a humidified 5% CO~2~ incubator at 37°C for 24 h. N-CNDs were dissolved in a cell culture medium containing 10 vol% FBS and 1 wt% of antibiotics. The cells were allowed to incubate with different concentrations of N-CNDs (0, 0.1, 0.25, 0.5, 1, 2.5, 5, and 10 mg/mL) for another 24 h at 37°C, respectively. After the cells were washed twice with PBS, the cell culture medium was changed. The relative cell viability was measured by MTT assay (n = 3). The absorbance was measured at 540 nm.

2.8 Photothermal effect of N-CNDs *in vitro* {#Section2.8}
--------------------------------------------

HepG2 cells at a density of 1 × 10^4^ were seeded onto 96-well plates. After incubation for 24 h, the cells were treated with different concentrations of N-CNDs (0, 0.1, 1, and 10 mg/mL) for 1 hour. After 10-min exposure of 808-nm light at 2 W/cm^2^, the cells were allowed to incubate for an additional 4 h. Cells treated without laser were used as a control group. To assess the photothermal effect of N-CNDs on the cells with and without exposure to NIR laser irradiation, the phototoxicity was measured by MTT assay (n = 3). To further evaluate the efficacy of PTT, HepG2 cells at a density of 3 × 10^4^ were incubated with and without N-CNDs (10 mg/mL) for 12 h and then irradiated with 808-nm laser light (2 W/cm^2^) for 10 min. After another incubation for 2 h, the cells were washed with PBS, stained with calcein-AM and PI, and then imaged by Leica TCS SP5II MP SMD FLIM (Leica, Deerfield, IL). The excitation laser was tuned to 488 and 594 nm.

2.9 Photothermal effect of N-CNDs *in vivo* {#Section2.9}
-------------------------------------------

Animal experiments were approved by the university in compliance with the regulations concerning experimental animals. To assess the therapeutic efficacy of N-CNDs, cancer model mice were prepared by inoculation with HepG2 cells at a density of 1 × 10^7^ to the left and right flanks of female Balb/c nude mice (5 weeks old, 20-25 g) and allowed to grow for 3-5 days until the tumor volume reached approximately 27 mm^3^ (n = 5). The tumor was treated by intratumoral injection of the solutions of PBS and N-CNDs (100 μL, 20 mg/mL) through a 26-gauge needle. The right tumors only were irradiated with 808-nm laser light (2 W/cm^2^) for 10 min. The left tumors without laser treatment were used as the control group. The tumor sizes were monitored by measuring the tumor diameters with a caliper. The tumor volume was determined according to the following equation:

V= (A × B

2

)/2

where A and B are the maximum and minimum diameter of the tumor [@B58]. The temperature change in the tumor region was monitored by a thermal camera for different groups. To evaluate the therapeutic efficacy of PTT, tumor tissues were harvested and fixed in 4% formaldehyde solution, embedded in paraffin blocks, sectioned into 5-μm slices, and mounted on glass slides. After H&E staining, the sections were observed by using an optical microscope (20× objectives).

2.10 Degradation test {#Section2.10}
---------------------

Degradation of N-CNDs was investigated by using UV/Vis absorbance. A 1-mL aliquot of N-CNDs (2 mg/mL in PBS, pH = 7.4) was added to 1 mL of H~2~O~2~ solution (200 mM or 2 M) or serum and incubated at 37ºC. The aliquot was collected at each time point and kept in the deep freezer. The absorption was measured at 450 nm (n = 3).

2.11 Toxicity test *in vivo* {#Section2.11}
----------------------------

Eight white Balb/c mice were intravenously injected with 100 μL of 20 mg/mL N-CNDs (a dose of 100 mg/kg). The other four mice were used as the controls. The mice were sacrificed to collect the major organs and blood for histological and blood analyses at 7 and 28 days post-injection of N-CNDs. Major organs (heart, lung, liver, kidney, spleen) were fixed in 10% formalin, embedded in paraffin, sectioned, and stained with H&E. The serum chemistry and complete blood panel were measured at the Center for Evaluation of Biomaterials.

3. Results {#Section3}
==========

3.1. Synthesis of N-CNDs and effect of N-doping {#Section3.1}
-----------------------------------------------

N-CNDs were synthesized by performing solvothermal carbonization of citric acid in the presence of nitric acid as an N source (Figure [1](#F1){ref-type="fig"}a). Briefly, an aqueous solution of citric acid with nitric acid was heated at 250 °C to be initially dehydrated to form polymer-like intermediates. These intermediates were then carbonized to form carbogenic cores, and simultaneously, oleylamine was grafted onto the surface of the core through amidation to suppress undesired inter-particle agglomeration during carbonization. Grafted oleylamine was subsequently replaced by ethanolamine to endow our N-CNDs with water solubility (Figure [S2](#SM1){ref-type="supplementary-material"}). We controlled the N content of N-CNDs by varying the molarities of nitric acid solutions, and N-CNDs prepared with 0, 1, 3, 5, 7, 10, 12, and 14 M (conc.) nitric acid solutions were coded as N0-, N1-, N3-, N5-, N7-, N10-, N12-, and N14-CNDs, respectively. Transmission electron microscopy showed that the N-CNDs were well dispersed with a particle size of \~3 nm (Figure [1](#F1){ref-type="fig"}b). Previously, nanostructures in this size range have been shown to be readily excreted via renal clearance [@B59]. Figure [1](#F1){ref-type="fig"}c shows partial graphitic structures or graphitic "clusters" (a few angstroms in size) that were found in the core of N-CNDs after low-temperature (\~300°C) carbonization. These graphitic clusters provide π electrons that would contribute to the formation of the highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) levels. X-ray photoelectron spectroscopy data showed that our N-CNDs contained a significant amount of N atoms that primarily originated from nitric acid and partially surface amide groups formed by ethanolamine, and their N content varied with the molar concentration of nitric acid (Figure [S3](#SM1){ref-type="supplementary-material"}). The N atoms that had lone pairs of electrons (or non-bonding orbitals) generated electronic states in between the HOMO and LUMO levels or the so-called intra-gap states, such as non-bonding (n) or defective states. Because intra-gap states reduce the energy gap, as illustrated in Figure [1](#F1){ref-type="fig"}d. N-CNDs that have more N atoms can generally absorb more photons of lower energy; however, the absorbance values of N-CNDs were saturated at the N content higher than N7 (Figure [1](#F1){ref-type="fig"}e). Consistently, photoluminescence spectroscopy of N-CNDs shows that a secondary peak is developed at around 500 nm as the N content increases, which also strongly suggests the formation of the N-induced intra-gap states (Figure [S4](#SM1){ref-type="supplementary-material"}). These intra-gap states have a major role in generating phonons (heat) through Shockley-Read-Hall (SRH) electron-hole recombination or other defect-related paths. Figure [1](#F1){ref-type="fig"}f indicates the PA spectrum at different nitrogen atoms. N7-CNDs showed the highest PA signal amplitude, which shows a trend similar to that of light absorption. Generally, PA signal amplitude is linearly proportional to absorbance, as shown in Equation 1.

Where Г indicates the Gruneisen parameter, *µ~a~* indicates the optical absorption coefficient, and *F*indicates the laser fluence. Figure [S5](#SM1){ref-type="supplementary-material"} shows that N-CNDs with more N atoms raised the surrounding temperature faster under NIR (λ = 680-808 nm) laser excitation. For instance, under λ = 808 nm excitation, N7-CNDs raised temperatures 20 times faster than did N0-CNDs and four times faster than did N1-CND. The temperature is raised faster because more nitrogen atoms generate more intra-gap states to facilitate carrier trapping from the LUMO to an intra-gap state and carrier relaxation between intra-gap states. We also detected photons of nearly half-gap energy (λ = 900-1200 nm) that were emitted in the final stage of SRH recombination (Figure [S6](#SM1){ref-type="supplementary-material"}), which directly proves the existence of intra-gap states in our N-CNDs. Because the quantum yield (Ф) of N-CNDs in the range of 900-1500 nm under 808-nm laser excitation was \~1% (Figure [S6](#SM1){ref-type="supplementary-material"}), it could be calculated according to Equation 2, which shows that 99% of excited-state electrons were thermally dissipated through SRH recombination:

where k~r~ indicates the radiative decay rate and k~nr~ indicates the non-radiative decay rate.

3.2 PA and photothermal characteristics of N-CNDs {#Section3.2}
-------------------------------------------------

The optical absorbance of N-CNDs increased with increasing concentration (Figure [S7](#SM1){ref-type="supplementary-material"}a), which indicated that N-CNDs have broad absorption in the NIR region (680-800 nm) and were well matched to the PA amplitude spectral distribution at the same concentration (Figure [S7](#SM1){ref-type="supplementary-material"}b). Although PA signal amplitude decreased with increasing wavelength, the PA signal could still be detected at 900 nm. The PA sensitivity at 680 nm was measured by testing the PA signal amplitude of N-CNDs at different concentrations; this measurement showed a linear relationship. The detection limit of the N-CNDs was 1 mg/mL (Figure [S8](#SM1){ref-type="supplementary-material"}). To investigate the performance of N-CNDs as a contrast agent, we directly compared the PA signals with those of popular conventional PA contrast agents, such as GNR and MB (Figure [S9](#SM1){ref-type="supplementary-material"}). At the same optical density, the normalized PA signal amplitude of N-CNDs (2.2 ± 0.2) was approximately two times higher than those of GNR (1.0 ± 0.1) and MB (1.3 ± 0.1) (Figure [2](#F2){ref-type="fig"}a). This result implies that N-CNDs have higher heat conversion efficiency than those of GNR and MB at the same optical density, which contains strong nonradiative energy decay, high heat conductance and capacity, and weak optical scattering [@B19], [@B60]. In addition, N-CNDs showed strong stability of the PA response to high-energy pulsed laser irradiation (Figure [2](#F2){ref-type="fig"}b). Pulsed laser at a 680-nm optical wavelength (15 mJ/cm^2^) was projected onto the samples. The PA signal amplitudes of N-CNDs and MB were relatively stable, but the PA signals from GNR decreased by 50% during the 300 pulses and entered the photobleaching state. Furthermore, the optical stability of N-CNDs for PTT was assessed by comparing GNR (Figure [2](#F2){ref-type="fig"}c). The optical absorption of N-CNDs varied from 0.43 to 0.40, whereas GNR varied from 0.39 to 0.28 under 660-nm continuous wave laser excitation over 10 min. To examine the photothermal properties of CNDs, the temperature changes of an aqueous solution of CNDs at diverse concentrations (0.1-20 mg/mL) were measured under irradiation by a 808-nm NIR laser (2 W/cm^2^), and DI water was used as the control (Figure [2](#F2){ref-type="fig"}d).

3.3 *In vivo/ex vivo* PA sentinel lymph node mapping {#Section3.3}
----------------------------------------------------

SLNs and vascular networks were photoacoustically visualized using an acoustic-resolution reflection-mode PA imaging system at 680-nm optical wavelength (Figure [S1](#SM1){ref-type="supplementary-material"}). Detecting SLNs is a clinically important issue for the diagnosis of metastatic cancer [@B13]. Figures [3](#F3){ref-type="fig"}a-c show the PA maximum amplitude projection (MAP) images, which clearly indicate the position of N-CNDs draining from an SLN. Figures [3](#F3){ref-type="fig"}e-g show the depth-resolved cross-sectional PA images of the corresponding yellow line in Figures [3](#F3){ref-type="fig"}a-c, respectively. Additionally, the depth information of the PA MAP image (Figure [3](#F3){ref-type="fig"}b) was encoded by a pseudo color, as shown in Figure [3](#F3){ref-type="fig"}d. Normally, the SLNs are located \~3 mm below the skin surface. Before injecting N-CNDs, the PA MAP image did not delineate the SLN but only showed the vasculature. After intradermal injection of N-CNDs, the PA signal amplitude of the SLN suddenly increased at 30 mins (167.2 ± 21.9%); subsequently, it decreased continuously until 180 min (33.1 ± 9.9%) (n = 3, Figure [3](#F3){ref-type="fig"}h). These results indicate that N-CNDs were initially collected and then eliminated from the SLN after circulating in the lymphatic system. To validate the results of the *in vivo* PA imaging, *ex vivo* PA imaging was performed by excising lymph nodes containing N-CNDs and normal lymph nodes from the axial region of rats (Figure [3](#F3){ref-type="fig"}i). Only the excised lymph nodes containing N-CNDs were detected in the PA MAP images (Figure [3](#F3){ref-type="fig"}j), whereas normal ones did not appear photoacoustically. Normally, the highest PA signal was measured from the SLN. However, an SLN injected with N-CNDs did not show the highest PA signal because the N-CNDs degraded. As the N-CNDs were fading away from the SLN, the strongest PA signal was observed at L2 (second lymph node). The PA contrast of the SLN and L2 were determined to be 299 ± 86% and 512 ± 65%, respectively (Figure [3](#F3){ref-type="fig"}k). Therefore, these results demonstrate the potential usefulness of N-CNDs for PA lymphoscintigraphy in clinical axillary staging of cancer.

3.4 *In vivo* whole-body PA imaging of renal clearance of N-CNDs {#Section3.4}
----------------------------------------------------------------

After subcutaneous injection of N-CNDs, whole-body PA imaging was performed to determine the bodily distribution and clearance of N-CNDs. Figures [4](#F4){ref-type="fig"}a-c and Figures [4](#F4){ref-type="fig"}d-f present the whole-body PA MAP images and depth-resolved cross-sectional PA images of the yellow line, respectively. Although the blood vessels are clearly shown in the control PA images (Figs. [4](#F4){ref-type="fig"}a and d), the bladder was invisible because of its transparency. Figures [4](#F4){ref-type="fig"}g-i show the depth-coded PA MAP images corresponding to Figures [4](#F4){ref-type="fig"}a-c, respectively. At 100 min post-injection of N-CNDs, an increased PA signal appeared in the bladder (Figs. [4](#F4){ref-type="fig"}b and 4e). Over time, the PA signal amplitude of the bladder was generally enhanced up to 450 min (1314 ± 237%) (n = 3, Figure [4](#F4){ref-type="fig"}j). However, the PA signal amplitude of the injection area decreased up to 500 min (124 ± 55 %) (n = 3, Figure [4](#F4){ref-type="fig"}k). These PA experimental results revealed that N-CNDs could be removed from the body by renal clearance after subcutaneous injection. The results showed that N-CNDs can contribute to the diagnosis of urinary tract diseases, including leaks and fistulas [@B61].

3.5 Degradation and *in vivo* toxicity {#Section3.5}
--------------------------------------

N-CNDs degradation was investigated using UV/Vis absorbance (Figs. [4](#F4){ref-type="fig"}l and m). Upon exposure to H~2~O~2~, the formation rate of hydroxyl radials increased in two ways: reduction of H~2~O~2~ at the conduction band and self-decomposition by irradiation. The former caused degradation of N-CNDs. As seen in Figure [4](#F4){ref-type="fig"}l, the decolorization rate increased when the H~2~O~2~ concentration increased from 0 to 1 M. The toxicity of N-CNDs was investigated *in vivo*. We monitored the behaviors of mice after intravenous injection of N-CNDs (100 mg/kg), and no apparent symptoms of toxic effects were observed within 1 month. The mice were sacrificed at days 7 and 30 for careful necropsy, and PBS treated mice were used as controls. The mice hearts, lungs, livers, kidneys, and spleens were fixed, sliced, and stained by hematoxylin and eosin (H&E) (Figure [S10](#SM1){ref-type="supplementary-material"}). Because of the high renal clearance rate of N-CNDs in the body, no noticeable organ destruction or inflammatory lesions were observed in the hearts, lungs, livers, kidneys, and spleens of the mice at 7 and 30 days, similar to the control group results. To further investigate the potential toxicology of N-CNDs in the body, a complete blood panel test and serum biochemistry assay were performed on N-CNDs-injected (100 mg/kg) white Balb/c mice at days 7 and 30. The measured parameter results were within normal ranges (Figure [S11](#SM1){ref-type="supplementary-material"}). The toxicity test results indicated that N-CNDs were biocompatible *in vivo* in mice for at least 30 days at our tested dose.

3.6 *In vitro/in vivo* PTT using N-CNDs {#Section3.6}
---------------------------------------

We investigated the *in vitro* cytotoxicity of N-CNDs and PTT efficacy in FL83B and HepG2. A high concentration (10 mg/mL) of N-CNDs caused no cytotoxicity in FL83B cells or HepG2 cells without laser irradiation (Figure [S12](#SM1){ref-type="supplementary-material"}a). In contrast, with 808-nm NIR laser irradiation, the viabilities of HepG2 cells decreased significantly as the concentration of N-CNDs increased (Figure [S12](#SM1){ref-type="supplementary-material"}b). Subsequently, a live/dead assay was performed to further verify the PTT efficacy of N-CNDs. Figure [S12](#SM1){ref-type="supplementary-material"}c shows that the cells incubated with N-CNDs and exposed to 808-nm laser light (2 W/cm^2^, 10 min) exhibited red fluorescence, which indicated cancer cell death. Figure [S12](#SM1){ref-type="supplementary-material"}d shows confocal images of FL83B cells and HepG2 cells treated with N-CNDs at excitation wavelengths of 405, 488, 561, and 633 nm. In the control group, all cells lived, as indicated by the green fluorescence. Based on the *in vitro* results, we further investigated the *in vivo*PTT of cancers using N-CNDs. Balb/c nude xenograft HepG2 tumor model mice (five mice per group) with a tumor volume of 27 mm^3^ were intratumorally injected with N-CNDs solution (20 mg/mL, 100 μL) and PBS as a control. The tumor regions of the PBS + laser group and N-CNDs + laser group were irradiated with the laser for 10 min, whereas the laser-untreated group was not irradiated for comparison. The temperature of the tumor area was monitored by a thermal camera at specific time points (Figures [5](#F5){ref-type="fig"}a and b). Under NIR laser irradiation, the tumor surface temperature of the N-CNDs + laser group rapidly increased from \~27°C to 50°C. The temperature change causes hyperthermia that can kill cancer cells. In contrast, the temperature of the tumor region of the control group and non-irradiated surrounding normal tissues showed no temperature change. To confirm the PTT efficacy of the N-CNDs, we monitored the tumor growth rates. After treatment with PBS regardless of laser irradiation, the tumor only continued to grow. Also, the tumor treated with N-CNDs without laser irradiation, the tumor volume increased over time. However, the tumor that was treated with N-CNDs and 808-nm NIR laser irradiation together completely disappeared (Figs. [5](#F5){ref-type="fig"}c and d). The anti-tumor effect was assessed by histological analysis of tumor tissues by H&E staining and TUNEL assay 12 hours after laser irradiation. The tumor tissues treated with N-CNDs + laser irradiation showed extensive nuclear shrinkage and fragmentation, which suggested that the PTT was enhanced*in vivo*. In contrast, cell destruction was negligible in tumor tissues treated with PBS, PBS + laser irradiation, and N-CNDs. From the fluorescence TUNEL assay (Figure [5](#F5){ref-type="fig"}e), the tumor tissues treated with N-CNDs + laser irradiation showed green fluorescence, which indicated cellular apoptosis. Normal areas stained blue, and TUNEL-positive areas stained green. In contrast, the tumor sections treated with PBS, N-CNDs, and PBS + laser irradiation showed only blue fluorescence. These results confirmed the feasibility of N-CNDs for PTT of cancer.

4. Conclusion {#Section4}
=============

We successfully verified the feasibility of a biocompatible optical-absorbing material, N-doped CND, from PA imaging of SLN and bladder, and cancer ablation PTT. The relative PA signal increased in SLNs after injection of N-CNDs, and degraded after circulating through the lymphatic system. Additionally, the PA signal in the bladder region increased dramatically after injection of N-CNDs, which indicated that N-CNDs were eliminated effectively in the urine. In cancer ablation PTT, the N-CNDs-injected region after laser irradiation treatment showed complete tumor ablation without recurrence. The light-absorbing material, N-CNDs, can be a promising agent for enhancement of optical contrast in PA imaging and to enhance the effect of PTT.
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![**Synthesis of N-CNDs and effect of nitrogen doping.** (a) Synthesis of N-CNDs. (b) TEM image of N-CNDs (scale bar = 5 nm). (c) Partial graphitic structures in the core of N-CNDs (scale bar = 2 nm). (d) Illustration of electronic structures and nitrogen-induced intra-gap states of N-CNDs. (e) Optical absorption spectrum of N-CNDs as a function of nitric acid concentration. (f) PA amplitude spectrum with different N-doped CNDs. HOMO, highest occupied molecular orbital; LUMO, lowest unoccupied molecular orbital.](thnov06p2196g001){#F1}

![**Photoacoustic (PA) and photothermal characteristics of N-CNDs.** (a) PA signal amplitude comparison of GNR, MB, and N-CNDs at the same optical density. (b) The stability of the PA responses of GNR, MB, and N-CNDs depending on the number of pulses of laser irradiation. (c) Optical absorption measurement of GNR and N-CNDs with and without laser irradiation. (d) Temperature elevation curves of N-CNDs at different concentrations (0, 0.1, 0.25, 0.5, 1, 2.5, 5, 10, 20 mg/mL). GNR, gold nanorod; MB, methylene blue.](thnov06p2196g002){#F2}

![***In vivo* photoacoustic (PA) sentinel lymph node (SLN) mapping with N-CNDs injection.** (a) PA maximum amplitude projection (MAP) image before N-CNDs injection. (b) PA MAP image 30 min after N-CNDs injection. (c) PA MAP image after 150 min of N-CNDs injection. (d) Depth-encoded PA MAP image after 30 min of N-CNDs injection. (e-g) Corresponding PA B-mode images of the dashed line area in (a-c). (h) PA signal profile in the SLN region from before injection to 180 min after the N-CNDs injection. (i) and (j) Photograph and PA MAP image, respectively, of SLNs excised after the N-CNDs injection (L1-L3) and control (L4-L6). (k) PA signal of the excised SLNs. SLN, sentinel lymph node; L, lymph node.](thnov06p2196g003){#F3}

![***In vivo* photoacoustic (PA) bladder imaging and degradation test using N-CNDs.** (a) Coronal (front) PA maximum amplitude projection (MAP) image before N-CNDs injection. (b) and (c) Coronal PA MAP image after 100 min and 450 min of N-CNDs injection. (d-f) Corresponding PA B-mode images at the dashed line region of (a-c). (g-i) Corresponding depth-encoded PA MAP images of the PA MAP images of (a-c). (j) and (k) PA signal profile in the bladder region (white dashed circle in (a-c)) and injected area (red dashed circle in (a-c)) from before injection to 500 min after the N-CNDs injection. (l) and (m) Serum biochemistry assay of N-CNDs-injected mice.](thnov06p2196g004){#F4}

![**Photothermal therapy (PTT) using N-CNDs**(a) Thermal camera images of N-CNDs injection with NIR laser irradiation. (b) Temperature profile of the injected area with and without NIR laser irradiation. (c) and (d) PTT monitoring and tumor volume profile of PBS and N-CNDs-injected models. (e) Histological analysis of tumor tissues with H&E staining and TUNEL assay 12 hours after PBS and N-CNDs injection without and with NIR laser irradiation. (black scale bar = 100 µm, white scale bar = 1000 µm).](thnov06p2196g005){#F5}
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